Post- End- Expiratory Pressure Affect the Alveolar Heterogeneity in Moderate and Sever ARDS Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: ling liu, PhD
- Phone Number: 13851435472
- Email: liulingdoctor@126.com
Study Contact Backup
- Name: haibo qiu, PhD
- Phone Number: professor 13951965301
- Email: haiboq@163.com
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210009
- Recruiting
- Nanjing Zhong-Da Hospital
-
Contact:
- Ling Liu, MD.
- Phone Number: 86-25-83272201
- Email: liulingdoctor@126.com
-
Contact:
- Haibo Qiu, PhD.,MD.
- Phone Number: 86-25-83272200
- Email: haiboq2000@yahoo.com.cn
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age≥18 or<80;
- Moderate or sever ARDS in 2012 <Berlin definition>;
- Applied mechanical ventilation;
- Consent signed.
Exclusion Criteria:
- Asthma or COPD;
- Cardiogenic edema;
- Sever neutropenia(<500/mm3);
- Hemodynamic astatic: DOPA or Dobutamine >15 µg/kg/ min; NE > 15ug /min;
- GCS coma score ≤12;
- Thoracic injury or surgery patients contradict EIT ;
- Refuse to join in trail;
- Included in other clinical trail。
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
alveolar hyper-distention; alveolar collapse;alveolar opening and closing;
Time Frame: September,1,2018-December 30, 2020
|
The study use Pulmo Vista 500 device (Drager co.),is intended to perform thoracic bioimpedance measurements by applying the technique of electrical impedance tomography (EIT)to evaluate alveolar hyper-distention(%of the lung volume); alveolar collapse(% of the lung volume);alveolar opening and closing(% of the lung volume).
|
September,1,2018-December 30, 2020
|
|
Trans-pulmonary pressure
Time Frame: September,1,2018-December 30, 2020
|
The researchers place tube in the esophagus and connect it to transmitter to measure esophageal pressure (mmHg)and calculate trans-pulmonary pressure(mmHg) to evaluate stress
|
September,1,2018-December 30, 2020
|
|
EELV
Time Frame: September,1,2018-December 30, 2020
|
The research use nitrogen wash out to measure EELV(end-expiratory lung volume, ml) to calculate dynamic strain and evaluate the strain
|
September,1,2018-December 30, 2020
|
|
peak pressure
Time Frame: September,1,2018-December 30, 2020
|
The researchers use ventilator to measure peak pressure(cmH2O) in patients with mechanical ventilation and without spontaneous breathing..
|
September,1,2018-December 30, 2020
|
|
plateau pressure
Time Frame: September,1,2018-December 30, 2020
|
The researchers use ventilator to do inspiration pause to measure plateau pressure(cmH2O) in patients with mechanical ventilation and without spontaneous breathing.
|
September,1,2018-December 30, 2020
|
|
tidal volume
Time Frame: September,1,2018-December 30, 2020
|
The researchers use ventilator to measure tidal volume(ml) in patients with mechanical ventilation and without spontaneous breathing..
|
September,1,2018-December 30, 2020
|
|
respiratory rate
Time Frame: September,1,2018-December 30, 2020
|
The researchers record the set respiratory rate(bpm) in patients with mechanical ventilation.
|
September,1,2018-December 30, 2020
|
|
flow
Time Frame: September,1,2018-December 30, 2020
|
The researchers record the set Flow (L/min) in patients with mechanical ventilation.
|
September,1,2018-December 30, 2020
|
|
FiO2
Time Frame: September,1,2018-December 30, 2020
|
The researchers record the set FiO2 ( fraction of inspiratory oxygen, %) in patients with mechanical ventilation.
|
September,1,2018-December 30, 2020
|
|
PaO2
Time Frame: September,1,2018-December 30, 2020
|
The researchers use blood gas analysis to measure PaO2( arterial oxygen pressure,mmHg)
|
September,1,2018-December 30, 2020
|
|
PaCO2
Time Frame: September,1,2018-December 30, 2020
|
The researchers use blood gas analysis to measure PaCO2( arterial carbon dioxide pressure,mmHg) .
|
September,1,2018-December 30, 2020
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SBP
Time Frame: September,1,2018-December 30, 2020
|
Recording SBP(systolic pressure, mmHg),which is always continuously monitored with invasive pressure monitor.
|
September,1,2018-December 30, 2020
|
|
DBP
Time Frame: September,1,2018-December 30, 2020
|
Recording DBP(Diastolic pressure, mmHg),which is always continuously monitored with invasive pressure monitor.
|
September,1,2018-December 30, 2020
|
|
CVP
Time Frame: September,1,2018-December 30, 2020
|
Recording CVP(central venous Pressure),which is always discontinuously monitored with jugular pressure monitor mmHg).
|
September,1,2018-December 30, 2020
|
|
vasopressor
Time Frame: September,1,2018-December 30, 2020
|
Recording clinical vasopressor usage including Norepinephrine( μg/Kg/min;)Epinephrine(μg/Kg/min) Dobutamine ( μg/Kg/min)
|
September,1,2018-December 30, 2020
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: haibo qiu, PhD, Nanjing Zhong-Da Hospital, Southeast University School of Medicine,China
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 20181129PEEP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.